why does semaglutide work better for me than tirzepatide vs. weight loss—what's the difference? 🤔Both have become very popular, but knowing which one Maintenance therapy on semaglutide or

GIP on its own does not produce meaningful weight loss

The bivalent degrader, designated GS-6791, is the first development candidate resulting from the previously announced Nurix-Gilead collaboration to develop and commercialize a pipeline of innovative targeted protein degradation therapies

Programs that can offer both, along with oral and injectable formats, give patients more room to find what actually works for their body

Int J Pharmacol 18(5):962971

Im adjusting the plan as we learn what works for this individual

In research contexts, this allows for deeper exploration of weight regulation, energy balance, and glucose control